Phase IIa trial of BIS-001 in adults with refractory focal seizures
Phase of Trial: Phase II
Latest Information Update: 19 Oct 2017
At a glance
- Drugs Huperzine A (Primary)
- Indications Seizures
- Focus Proof of concept; Therapeutic Use
- 19 Oct 2017 According to a Biscayne Neurotherapeutics media release, this trial is expected to begin in early 2018.
- 01 Feb 2017 New trial record
- 27 Jan 2017 According to Biscayne Neurotherapeutics media release, this phase IIa is expected to be initiated in 2018 if phase Ib trial of BIS-001 goes well.